Chinese vitamin C sellers are off the hook for violating U.S. antitrust law because they were compelled by the Chinese government to set prices and reduce quantities for the vitamin.

The U.S. Court of Appeals for the Second Circuit on Tuesday vacated a $147 million judgment and injunctive relief secured at trial in Brooklyn federal court by two plaintiff companies who said they were the victims of a price-fixing conspiracy.